Skip to main content

The “Company Name” field currently displays the company associated with the drug identification number (DIN) as of today. A fix will be implemented shortly so the fields will show the company name as it was when the report was originally posted. This issue does not impact the data that can be extracted from the website using the Application Programming Interface (API).

Reports for TERBINAFINE

Ingredient

TERBINAFINE

Shortage reports
Brand name	Strength	Dosage	Status	Date Created	Date Updated	Reports
APO-TERBINAFINE	250MG	TABLET	Resolved	2018-02-01	2018-04-15	37989
APO-TERBINAFINE	250MG	TABLET	Resolved	2018-01-31	2018-09-21	37746
APO-TERBINAFINE	250MG	TABLET	Resolved	2017-11-01	2017-11-23	27773
APO-TERBINAFINE	250MG	TABLET	Resolved	2017-05-24	2017-07-19	11053
APO-TERBINAFINE	250MG	TABLET	Resolved	2023-09-15	2023-12-22	204417
APO-TERBINAFINE	250MG	TABLET	Resolved	2018-11-16	2019-01-17	67034
APO-TERBINAFINE	250MG	TABLET	Resolved	2023-12-01	2024-01-05	212377
APO-TERBINAFINE	250MG	TABLET	Resolved	2024-04-12	2024-07-26	225005
APO-TERBINAFINE	250MG	TABLET	Resolved	2024-05-03	2024-07-26	227065
APO-TERBINAFINE	250MG	TABLET	Resolved	2025-10-16	2025-12-05	269757

Previous
1
2
3
4
5
Next

Showing 11 to 20 of 43

Discontinuation reports
Brand name	Strength	Dosage	Status	Date Created	Date Updated	Reports
LAMISIL	250MG	TABLET	To be discontinued	2024-11-28	2024-11-28	244096
TEVA-TERBINAFINE	250MG	TABLET	Discontinued	2025-05-28	2025-05-28	258663
TEVA-TERBINAFINE	250MG	TABLET	Discontinued	2025-05-28	2025-05-28	258780
TEVA-TERBINAFINE	250MG	TABLET	Discontinued	2025-09-02	2025-09-02	266365

1

Showing 1 to 4 of 4